{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T17:28:04Z","timestamp":1775064484855,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"51","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T00:00:00Z","timestamp":1635206400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.vaccine.2021.10.017","type":"journal-article","created":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T18:30:41Z","timestamp":1637605841000},"page":"7510-7520","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["T cell and memory B cell responses in tetravalent DNA, tetravalent inactivated and tetravalent live-attenuated prime-boost dengue vaccines in rhesus macaques"],"prefix":"10.1016","volume":"39","author":[{"given":"Peifang","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vihasi","family":"Jani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2878-5263","authenticated-orcid":false,"given":"Alison","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nishith","family":"Nagabhushana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maya","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian J.","family":"Morrison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Defang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4839","key":"10.1016\/j.vaccine.2021.10.017_b0005","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1126\/science.239.4839.476","article-title":"Pathogenesis of dengue: challenges to molecular biology","volume":"239","author":"Halstead","year":"1988","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.vaccine.2021.10.017_b0010","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1590\/S1020-49892002000400003","article-title":"Enhanced severity of secondary dengue-2 infections: death rates in 1981 and 1997 Cuban outbreaks","volume":"11","author":"Guzman","year":"2002","journal-title":"Rev Panam Salud Publica"},{"issue":"1","key":"10.1016\/j.vaccine.2021.10.017_b0015","doi-asserted-by":"crossref","first-page":"73","DOI":"10.4269\/ajtmh.2012.12-0361","article-title":"A phase II, randomized, safety and immunogenicity study of a re-derived, live-attenuated dengue virus vaccine in healthy adults","volume":"88","author":"Thomas","year":"2013","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"10.1016\/j.vaccine.2021.10.017_b0020","doi-asserted-by":"crossref","first-page":"441","DOI":"10.4269\/ajtmh.14-0625","article-title":"A Phase II, Randomized, Safety and Immunogenicity Trial of a Re-Derived, Live-Attenuated Dengue Virus Vaccine in Healthy Children and Adults Living in Puerto Rico","volume":"93","author":"Bauer","year":"2015","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"10.1016\/j.vaccine.2021.10.017_b0025","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4269\/ajtmh.13-0452","article-title":"Safety and immunogenicity of a rederived, live-attenuated dengue virus vaccine in healthy adults living in Thailand: a randomized trial","volume":"91","author":"Watanaveeradej","year":"2014","journal-title":"Am J Trop Med Hyg"},{"issue":"4","key":"10.1016\/j.vaccine.2021.10.017_b0030","doi-asserted-by":"crossref","first-page":"698","DOI":"10.4269\/ajtmh.14-0268","article-title":"An adjuvanted, tetravalent dengue virus purified inactivated vaccine candidate induces long-lasting and protective antibody responses against dengue challenge in rhesus macaques","volume":"92","author":"Fernandez","year":"2015","journal-title":"Am J Trop Med Hyg"},{"issue":"6","key":"10.1016\/j.vaccine.2021.10.017_b0035","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.4269\/ajtmh.16-0634","article-title":"Phase 1 Randomized Study of a Tetravalent Dengue Purified Inactivated Vaccine in Healthy Adults in the United States","volume":"96","author":"Schmidt","year":"2017","journal-title":"Am J Trop Med Hyg"},{"issue":"5","key":"10.1016\/j.vaccine.2021.10.017_b0040","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.vaccine.2010.11.050","article-title":"Evaluation of a prototype dengue-1 DNA vaccine in a Phase 1 clinical trial","volume":"29","author":"Beckett","year":"2011","journal-title":"Vaccine"},{"issue":"32","key":"10.1016\/j.vaccine.2021.10.017_b0045","doi-asserted-by":"crossref","first-page":"4444","DOI":"10.1016\/j.vaccine.2019.06.083","article-title":"Enhanced immunogenicity and protective efficacy of a tetravalent dengue DNA vaccine using electroporation and intradermal delivery","volume":"37","author":"Williams","year":"2019","journal-title":"Vaccine"},{"issue":"42","key":"10.1016\/j.vaccine.2021.10.017_b0050","doi-asserted-by":"crossref","first-page":"7261","DOI":"10.1016\/j.vaccine.2011.07.019","article-title":"Development of dengue DNA vaccines","volume":"29","author":"Danko","year":"2011","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2021.10.017_b0055","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.virol.2009.10.023","article-title":"Protection against dengue virus by non-replicating and live attenuated vaccines used together in a prime boost vaccination strategy","volume":"396","author":"Simmons","year":"2010","journal-title":"Virology"},{"issue":"45","key":"10.1016\/j.vaccine.2021.10.017_b0060","doi-asserted-by":"crossref","first-page":"6103","DOI":"10.1016\/j.vaccine.2017.09.059","article-title":"Evaluation of T and B memory cell responses elicited by the pandemic H1N1 vaccine in HIV-infected and HIV-uninfected individuals","volume":"35","author":"Sun","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.10.017_b0065","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.virol.2015.02.017","article-title":"RIG-I in RNA virus recognition","volume":"479\u2013480","author":"Kell","year":"2015","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.vaccine.2021.10.017_b0070","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.virol.2008.10.022","article-title":"Functional characterization of ex vivo blood myeloid and plasmacytoid dendritic cells after infection with dengue virus","volume":"383","author":"Sun","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2021.10.017_b0075","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3389\/fimmu.2012.00079","article-title":"The Role of TLR2 in Infection and Immunity","volume":"3","author":"Oliveira-Nascimento","year":"2012","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2021.10.017_b0080","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.virol.2011.08.026","article-title":"Infection and activation of human peripheral blood monocytes by dengue viruses through the mechanism of antibody-dependent enhancement","volume":"421","author":"Sun","year":"2011","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.vaccine.2021.10.017_b0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000086","article-title":"Host gene expression profiling of dengue virus infection in cell lines and patients","volume":"1","author":"Fink","year":"2007","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2021.10.017_b0090","first-page":"121","article-title":"CXCL10\/IP-10 in infectious diseases pathogenesis and potential therapeutic implications","volume":"22","author":"Liu","year":"2011","journal-title":"Cytokine Growth Factor Rev"},{"issue":"3","key":"10.1016\/j.vaccine.2021.10.017_b0095","first-page":"202","article-title":"Role of TNF alpha, IL-6 and CXCL10 in Dengue disease severity","volume":"10","author":"Masood","year":"2018","journal-title":"Iran J Microbiol"},{"issue":"5","key":"10.1016\/j.vaccine.2021.10.017_b0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0125228","article-title":"Innate responses induced by whole inactivated virus or subunit influenza vaccines in cultured dendritic cells correlate with immune responses in vivo","volume":"10","author":"Stoel","year":"2015","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.vaccine.2021.10.017_b0105","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/nri2510","article-title":"Towards an understanding of the adjuvant action of aluminium","volume":"9","author":"Marrack","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2021.10.017_b0110","first-page":"406","article-title":"Mechanism of immunopotentiation and safety of aluminum adjuvants","volume":"3","author":"Hogenesch","year":"2012","journal-title":"Front Immunol"},{"issue":"27","key":"10.1016\/j.vaccine.2021.10.017_b0115","doi-asserted-by":"crossref","first-page":"12192","DOI":"10.1073\/pnas.1005443107","article-title":"Preferential localization of IgG memory B cells adjacent to contracted germinal centers","volume":"107","author":"Aiba","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"10.1016\/j.vaccine.2021.10.017_b0120","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1189\/jlb.68.6.793","article-title":"DNA vaccination: antigen presentation and the induction of immunity","volume":"68","author":"Shedlock","year":"2000","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.vaccine.2021.10.017_b0125","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/978-1-59745-561-9_9","article-title":"Gene gun delivery systems for cancer vaccine approaches","volume":"542","author":"Aravindaram","year":"2009","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.vaccine.2021.10.017_b0130","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1476-4598-10-3","article-title":"Improvement of different vaccine delivery systems for cancer therapy","volume":"10","author":"Bolhassani","year":"2011","journal-title":"Mol Cancer"},{"issue":"9","key":"10.1016\/j.vaccine.2021.10.017_b0135","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1080\/21645515.2019.1581536","article-title":"Cell-mediated immune responses to different formulations of a live-attenuated tetravalent dengue vaccine candidate in subjects living in dengue endemic and non-endemic regions","volume":"15","author":"Moris","year":"2019","journal-title":"Hum Vaccin Immunother"},{"issue":"8","key":"10.1016\/j.vaccine.2021.10.017_b0140","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1128\/JCM.00305-07","article-title":"Dengue virus detection using whole blood for reverse transcriptase PCR and virus isolation","volume":"45","author":"Klungthong","year":"2007","journal-title":"J Clin Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2021.10.017_b0145","doi-asserted-by":"crossref","first-page":"341","DOI":"10.4269\/ajtmh.2011.10-0501","article-title":"Safety and immunogenicity of a tetravalent live-attenuated dengue vaccine in flavivirus-naive infants","volume":"85","author":"Watanaveeradej","year":"2011","journal-title":"Am J Trop Med Hyg"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21013256?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21013256?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:04:26Z","timestamp":1759403066000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X21013256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":29,"journal-issue":{"issue":"51","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S0264410X21013256"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.10.017","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"T cell and memory B cell responses in tetravalent DNA, tetravalent inactivated and tetravalent live-attenuated prime-boost dengue vaccines in rhesus macaques","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.10.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}